UM

Browse/Search Results:  1-1 of 1 Help

Filters                    
Selected(0)Clear Items/Page:    Sort:
IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities Journal article
Cancer Letters, 2013,Volume: 340,Issue: 1,Page: 88
Authors:  Li Y.-B.;  Wang Z.-Q.;  Yan X.;  Chen M.-W.;  Bao J.-L.;  Wu G.-S.;  Ge Z.-M.;  Zhou D.-M.;  Wang Y.-T.;  Li R.-T.
Favorite  |  View/Download:4/0  |  Submit date:2018/10/31
Angiogenesis  Breast Cancer  Egfr  Irreversible Tki